Dobutamine is used in acute decompensated heart failure. Unlike dopamine, dobutamine does NOT increase renal blood flow significantly because:

• A Dobutamine's predominant beta-1 agonism increases cardiac output which reflexively constricts renal vessels
• B Dobutamine has equal alpha-1 and beta-2 activity in renal vasculature causing net neutral effect
• C Dobutamine lacks D1 receptor agonist activity that dopamine uses to dilate renal vasculature ✓
• D Dobutamine is extensively metabolized before reaching the renal vasculature

Explanation

Dopamine at low doses (1–3 mcg/kg/min) stimulates D1 receptors in renal and mesenteric vasculature, causing selective vasodilation and increased renal blood flow. At higher doses, dopamine also activates beta-1 (increasing cardiac output) and eventually alpha-1 receptors (vasoconstriction). Dobutamine is a synthetic catecholamine with predominant beta-1 > beta-2 > alpha-1 activity but NO dopaminergic (D1) receptor activity. Thus, dobutamine increases cardiac output without the selective renal vasodilatory effect of low-dose dopamine.

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.